CAS: 509077-99-0 - Ertumaxomab
Fórmula:Unspecified
- Sinónimos:
- Immunoglobulin G2a, anti-(human HER-2/neu) (mouse monoclonal 2502A/TP-A-02/TPBs03 heavy chain), disulfide with mouse monoclonal 2502A/TP-A-02/TPBs03 light chain, disulfide with immunoglobulin G2b, anti-(human CD3 (antigen)) (rat monoclonal 26/II/6-1.2/TPBs03 heavy chain), disulfide with rat monoclonal 26/II/6-1.2/TPBs03 light chain
- Immunoglobulin G2a, anti-(human neu (receptor)) (mouse monoclonal 2502A/TP-A-02/TPBs03 heavy chain), disulfide with mouse monoclonal 2502A/TP-A-02/TPBs03 light chain, disulfide with immunoglobulin G2b, anti-(human CD3 (antigen)) (rat monoclonal 26/II/6-1.2/TPBs03 heavy chain), disulfide with rat monoclonal 26/II/6-1.2/TPBs03 light chain
- Immunoglobulin G2a, anti-(human c-erbB2 (receptor)) (mouse monoclonal 2502A/TP-A-02/TPBs03 heavy chain), disulfide with mouse monoclonal 2502A/TP-A-02/TPBs03 light chain, disulfide with immunoglobulin G2b, anti-(human CD3 (antigen)) (rat monoclonal 26/II/6-1.2/TPBs03 heavy chain), disulfide with rat monoclonal 26/II/6-1.2/TPBs03 light chain
- Ertumaxomab
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | Ertumaxomab REF: 3D-CLA1169CAS: 509077-99-0 | - - - | A consultar | Seg 04 Nov 24 |
Ertumaxomab
CAS:509077-99-0
Anti-human CD22 recombinant antibody bispecific antibody targeting HER2/neu and CD3.
Ref: 3D-CLA1169
| Tamanho indefinido | A consultar |
Entrega estimada em Estados Unidos, Segunda-feira 4 de Novembro de 2024
